Literature DB >> 10359667

Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines.

J Reckless1, D J Grainger.   

Abstract

We have identified an amino acid sequence, termed peptide 3, corresponding to amino acids 51-62 of the mature human monocyte chemoattractant protein-1 (MCP-1), which inhibits human mononuclear-cell and THP-1-cell migration induced by a wide range of chemokines. For example, peptide 3 inhibited MCP-1-induced THP-1 migration in a transwell assay with an ED50 of approx. 8 microM. Peptide 3 binds directly to THP-1 cells with an association constant of approx. 10 microM, and is therefore likely to be a direct receptor antagonist for CC and CXC chemokine receptors. By performing a structure-function analysis of this peptide, we have identified a sequence variant that shows an approx. 3-4-fold greater potency as an inhibitor of chemokine-induced migration [Leu4Ile11 peptide 3 (1-12)]. Furthermore, unlike peptide 3, which binds to the Duffy antigen receptor for chemokines on human erythrocytes with a similar affinity to the specific chemokine receptors on THP-1 cells, the Leu4Ile11 peptide 3 (1-12) sequence variant shows at least 20-fold greater selectivity for the specific receptors. Derivatives of Leu4Ile11 peptide 3 (1-12) are therefore the best candidates among the molecules we have investigated for use as a chemokine inhibitor in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359667      PMCID: PMC1220314     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 2.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

3.  A cDNA clone used to study mRNA inducible in human tonsillar lymphocytes by a tumor promoter.

Authors:  K Obaru; M Fukuda; S Maeda; K Shimada
Journal:  J Biochem       Date:  1986-03       Impact factor: 3.387

4.  Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture.

Authors:  A J Valente; D T Graves; C E Vialle-Valentin; R Delgado; C J Schwartz
Journal:  Biochemistry       Date:  1988-05-31       Impact factor: 3.162

5.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

Authors:  T N Kledal; M M Rosenkilde; F Coulin; G Simmons; A H Johnsen; S Alouani; C A Power; H R Lüttichau; J Gerstoft; P R Clapham; I Clark-Lewis; T N Wells; T W Schwartz
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

7.  The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.

Authors:  J Elsner; H Petering; R Höchstetter; D Kimmig; T N Wells; A Kapp; A E Proudfoot
Journal:  Eur J Immunol       Date:  1997-11       Impact factor: 5.532

8.  Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin.

Authors:  S J Foster; D M Aked; J M Schröder; E Christophers
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

9.  Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties.

Authors:  B J Rollins; E D Morrison; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

Authors:  C G Larsen; A O Anderson; E Appella; J J Oppenheim; K Matsushima
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

View more
  5 in total

1.  The peptide of sequence 66-77 of monocytic chemotactic protein (MCP-1) inhibits inflammation in experimental animals.

Authors:  T L Krasnikova; T I Arefieva; M G Melekhov; N B Kukhtina; M V Sidorova; A S Molokoedov; V N Bushuev; Zh D Bespalova; E I Chazov
Journal:  Dokl Biol Sci       Date:  2005 Sep-Oct

2.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

3.  The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo.

Authors:  J Reckless; L M Tatalick; D J Grainger
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

4.  Effects of synthetic monocyte chemotactic protein-1 fragment 65-76 on neointima formation after carotid artery balloon injury in rats.

Authors:  N B Kukhtina; P P Bashtrykov; Zh D Bespalova; M V Sidorova; T I Aref'eva; V O Sokolov; T L Krasnikova
Journal:  Neurosci Behav Physiol       Date:  2009-01-13

5.  Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction.

Authors:  David J Grainger; Andrew M L Lever
Journal:  Retrovirology       Date:  2005-04-04       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.